Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study
Titel:
Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study
Auteur:
Bringhen, Sara Oliva, Stefania Liberati, Anna Marina Belotti, Angelo Larocca, Alessandra Bonello, Francesca Gaidano, Gianluca Bertazzoni, Paola Esma, Fabrizio Stocchi, Raffaella Malfitano, Alessandra Ribolla, Rossella Di Sano, Chiara Aschero, Simona Patriarca, Francesca De Paoli, Lorenzo Cafro, Anna Maria Sonneveld, Pieter Palumbo, Antonio Boccadoro, Mario